Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 9:30 AM ISTDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
Johnson multiple myeloma drug succeeds in first-line combination study Ruby Khatun Khatun23 Nov 2017 10:00 AM ISTJohnson and Johnson's blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or...
